ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing Insights

DALLAS, March 03, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair drug testing, is proud to announce the launch of its innovative Quartile Reporting feature. This industry-first enhancement empowers organizations with unprecedented insights into drug test results, enabling data-driven decision-making and fostering safer, more productive workplaces.

The new Quartile Reporting feature allows clients to see where a candidate’s or employee’s test results fall within a range of positive reports collected over the past 12 months. By segmenting results into four quartiles – Lower, Median, Upper, and Highest – this advanced reporting provides real-time context and benchmarks for substance use trends within the workforce.

“Our mission has always been to provide our clients with the most reliable and actionable drug testing solutions," said Brian Hullinger, Chief Executive Officer and President of Psychemedics. “With Quartile Reporting, we’re bringing a new level of clarity and precision to the industry, enabling organizations to better understand drug test results and make informed decisions that enhance workplace safety and compliance.”

Key Benefits of Quartile Reporting

  • Enhanced Insights: Understand where individual results rank among other positives, offering valuable benchmarks for decision-making.
  • Real-Time Analytics: Access up-to-date data and trends, empowering clients to act with confidence.
  • Data-Driven Decisions: Use detailed context to support hiring, retention, and compliance strategies.

A Breakthrough in Workplace Drug Testing

As the drug testing landscape continues to evolve, Psychemedics is leading the way in delivering cutting-edge solutions that address the unique challenges faced by today’s employers. Quartile Reporting is part of Psychemedics’ ongoing efforts to innovate and meet the growing demand for more comprehensive, insightful drug testing data.

This enhancement is available to all Psychemedics clients at no additional cost, underscoring the company’s dedication to delivering exceptional value and driving industry advancement.

“We’re constantly striving to bring our clients tools that improve their programs and set new standards in the industry,” Brian Hullinger added. “Quartile Reporting exemplifies our commitment to innovation and our mission to empower organizations with the insights they need to thrive.”

About Psychemedics 

Psychemedics Corporation is a leading global provider of innovative hair testing for drugs of abuse. With a commitment to accuracy and reliability, the company offers cutting-edge drug testing solutions. Psychemedics Corporation is dedicated to providing valuable insights and maintaining the highest standards in substance abuse testing.

Investor Relations:
Phone: 978-206-8220
Email: InvestorRelations@psychemedics.com 


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.82
-1.71 (-0.74%)
AAPL  271.86
-1.22 (-0.45%)
AMD  214.16
-1.18 (-0.55%)
BAC  55.00
-0.28 (-0.51%)
GOOG  313.80
-0.75 (-0.24%)
META  660.09
-5.86 (-0.88%)
MSFT  483.62
-3.86 (-0.79%)
NVDA  186.50
-1.04 (-0.55%)
ORCL  194.91
-2.30 (-1.17%)
TSLA  449.72
-4.71 (-1.04%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.